ArticleScience translational medicine2026

Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models.

Mathieu Rouanne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.